Skip to Main Content

Paper Details

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.
Blood Adv
2
2023
AML, ICUS, MDS, MPN, MPNs, Myelodysplastic neoplasms, acute myeloid leukemia, blasts, hematopoietic disorders, idiopathic cytopenia, myelodysplastic neoplasms, myeloproliferative neoplasms, participants, patients
Author NameAffiliation
Rafael BejarMoores Cancer Center, University of California San Diego
Dana E RollisonMoffitt Cancer Center
Dana E RollisonMoffitt Cancer Center
  • 1 - 3

Datasets

Release 1.2